Background: Diabetic nephropathy (DN) is one of the most common and severe microvascular complications of diabetes mellitus (DM) and the leading cause of end-stage renal disease. Although hemoxygenase (HO) is cytoprotective, the potential renoprotective mechanisms of HO-1 induction remain to be explored. Aim: The aim of this study is to evaluate the possible protective effect of HO induction on streptozotocin (STZ)-induced early DN and various mechanisms underlie this effect in rats. Materials & methods: Single intraperitoneal (i.p.) injection of STZ(60mg/kg) was administered to induce early DN in rats. Four weeks after STZ injection, the diabetic rats were divided into four groups (10 rats each), namely, STZdiabetic, Hemin treated diabetic, Hemin and chromium-mesoporphyrin (CrMP) treated diabetic and CrMP treated diabetic group. The normal rats were chosen as control group .The diabetic rats received either hemin(15 mg/kg,ip) or CrMP(4 µmol/kg ,ip) alone or combined treatment of both , twice weekly for 4 weeks.DN was assessed, eight weeks of STZ injection, by measuring plasma adiponectin, serum insulin, glucose and creatinine levels, renal hemoxygenase -1(HO-1)concentration , monocyte chemoattractant protein -1(MCP-1),intercellular adhesion molecule -1(ICAM-1), nuclear factor -Kappa beta(NF-κB), tumor necrosis factor -alpha (TNF-α), hydroxyprolin, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and urinary albumin , collagen, creatinine and 8-isoprostane and8-hydroxyguanosine (8-OHDG) levels. Results: Hemin -induced HO upregulation, in STZ -diabetic rats suppressed the hyperglycemia with increased adiponectin and insulinotropic effect. Correspondingly, hemin reduced the markers of kidney dysfunction including albuminuria, collagen and creatinine excretion together with reduced serum creatinine level, suggesting improved kidney function. Similarly, hemin, suppressed renal proinflammatory chemokines, MCP-1, ICAM-1with parallel reduction in renal proinflammatory cytokine TNF-α and the inflammatory/oxidative transcription factor, NF-κB, in STZ-diabetic rats. Moreover hemin therapy was associated with marked reduction in STZ induced elevation in renal fibrotic marker, hydroxyprolin. Furthermore, hemin significantly decreased the enhanced renal NADPH oxidase with parallel reduction of urinary 8-isoprostane and 8-OHDG, surrogate urinary markers of oxidative stress. Contrarily, coadministering the HO inhibitor, CrMP with the HO-inducer, hemin nullified the antidiabetic and renoprotective effects, whereas administering CrMP alone abrogated HO level, aggravated hyperglycemia, further increased renal MCP-1, ICAM-1, NF-κB, TNF-α, hydroxyprolin with deterioration of oxidative stress markers and exacerbating renal dysfunction in diabetic animals. CONCLUSION: These findings suggest that the reduction of renal injury in diabetic rats upon induction of HO-1 was associated with decreased renal oxidative stress, fibrosis and inflammation, implicating the role of HO-1 induction as a future treatment of DN. 
INTRODUCTION
Although many therapeutic interventions have been shown to delay the development or retard the progression of DN, currently no intervention has been able to halt or reverse its progression (10).
Therefore, better therapeutic modalities are urgently needed. The HO system may constitute a novel approach that could be explored against diabetes and its related renal and metabolic complications. This study highlights the potential therapeutic benefit of HO-1 induction, through hem into protect the kidney from diabetic renal injury. 
Materials and Methods

Animals
Effect of hemin therapy on renal MCP-1, ICAM-
1, TNF-α and NF-ĸB in STZ diabetic rats
We investigated the effects of enhancing HO system, through hemin therapy, on these inflammatory markers, in STZ-diabetic rats. As These results suggest that inflammation is critically involved in the pathogenesis of DN and HO system could play a central role.
Effect of hemin therapy on renal NADPH Oxidase and Oxidative Stress
Renal cortical NADPH oxidase activity was significantly elevated in STZ diabetic rats compared to control normal group (Fig 4(a) ). The 
Effects of hemin on STZ-induced renal hydroxyproline level
The renal hydroxyproline level in STZ induced diabetic rats was significantly higher compared to control normal group (Fig6).Induction of HO-1 with hemin markedly reduced the elevated renal hydroxyproline content by about 1.6-fold , an effect which is reversed by CrMP treatment and blunted when hemin combined with CrMP, to be comparable to that of diabetic group. The results suggest that HO upregulation could efficiently prevent renal fibrosis in diabetic rats. 
